Preimplantation genetic screening (PGS) determines the chromosomal status of an embryo by screening all 23 chromosome pairs prior to transfer in an IVF cycle.
This report contains market size and forecasts of Preimplantation Genetic Screening (PGS) Technology in Global, including the following market information:
Global Preimplantation Genetic Screening (PGS) Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Preimplantation Genetic Screening (PGS) Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Next-generation Sequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preimplantation Genetic Screening (PGS) Technology include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Coopersurgical, Natera, Takara Bio, Oxford Gene Technology and INVICTA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preimplantation Genetic Screening (PGS) Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preimplantation Genetic Screening (PGS) Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Preimplantation Genetic Screening (PGS) Technology Market Segment Percentages, by Type, 2021 (%)
Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism
Global Preimplantation Genetic Screening (PGS) Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Preimplantation Genetic Screening (PGS) Technology Market Segment Percentages, by Application, 2021 (%)
Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others
Global Preimplantation Genetic Screening (PGS) Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Preimplantation Genetic Screening (PGS) Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preimplantation Genetic Screening (PGS) Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Preimplantation Genetic Screening (PGS) Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer
Coopersurgical
Natera
Takara Bio
Oxford Gene Technology
INVICTA
Genea
Progenesis
Igenomix
Reproductive Health and Wellness Center